Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

This is a study of oral nisin administration in patients with OSCC who are undergoing complete surgical resection surgery with or without adjuvant radiation/chemoradiation as part of their routine care at the University of California, San Francisco (UCSF).

Trial Details

NCT ID
NCT06097468
Phase
PHASE1 / PHASE2
Sponsor
University of California, San Francisco
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
Locations (sample)
  • San Francisco, California, United States|37.77493,-122.41942

Key Eligibility Criteria

  • Participants with a suspected clinical diagnosis of oral cavity squamous cell carcinoma (OSCC) who are planning to undergo a diagnostic biopsy. Not…
  • OSCC mass must be \>= 2cm in size.
  • Non-metastatic OSCC (no distant metastases allowed; metastasis to the neck is eligible).
  • Participants must be planning for a complete OSCC surgical resection, with or without adjuvant radiation/chemoradiation, at UCSF, as part of their …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →